ZA99694B - Transfecting compounds which are sensitive to reducing conditions, pharmaceutical compositions containing them and their applications. - Google Patents

Transfecting compounds which are sensitive to reducing conditions, pharmaceutical compositions containing them and their applications.

Info

Publication number
ZA99694B
ZA99694B ZA9900694A ZA99694A ZA99694B ZA 99694 B ZA99694 B ZA 99694B ZA 9900694 A ZA9900694 A ZA 9900694A ZA 99694 A ZA99694 A ZA 99694A ZA 99694 B ZA99694 B ZA 99694B
Authority
ZA
South Africa
Prior art keywords
sensitive
applications
pharmaceutical compositions
compositions containing
reducing conditions
Prior art date
Application number
ZA9900694A
Inventor
Gerardo Byk
Catherine Dubertret
Bruno Pitard
Daniel Scherman
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA99694B publication Critical patent/ZA99694B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA9900694A 1998-01-30 1999-01-28 Transfecting compounds which are sensitive to reducing conditions, pharmaceutical compositions containing them and their applications. ZA99694B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9801065A FR2774394B1 (en) 1998-01-30 1998-01-30 TRANSFECTANT COMPOUNDS SENSITIVE TO REDUCING CONDITIONS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR APPLICATIONS

Publications (1)

Publication Number Publication Date
ZA99694B true ZA99694B (en) 1999-07-28

Family

ID=9522388

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900694A ZA99694B (en) 1998-01-30 1999-01-28 Transfecting compounds which are sensitive to reducing conditions, pharmaceutical compositions containing them and their applications.

Country Status (3)

Country Link
FR (1) FR2774394B1 (en)
PL (1) PL343203A1 (en)
ZA (1) ZA99694B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US5837533A (en) * 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
FR2730637B1 (en) * 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa PHARMACEUTICAL COMPOSITION CONTAINING NUCLEIC ACIDS, AND USES THEREOF
FR2741066B1 (en) * 1995-11-14 1997-12-12 Rhone Poulenc Rorer Sa NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS

Also Published As

Publication number Publication date
FR2774394A1 (en) 1999-08-06
PL343203A1 (en) 2001-07-30
FR2774394B1 (en) 2002-04-26

Similar Documents

Publication Publication Date Title
HUP0200312A3 (en) Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
HUP0102372A3 (en) Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same
HUP0102483A3 (en) Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol
IL190216A0 (en) Novel substituted imidazole compounds, their preparation and pharmaceutical compositions comprising them
HUP0200714A3 (en) Pharmaceutical compounds, pharmaceutical compositions containing them and their use
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
HUP0100867A3 (en) Pharmaceutical compositions containing celecoxib
HK1038690A1 (en) Powdery pernasal compositions.
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HK1028352A1 (en) Solid pharmaceutical composition containing benzofurane derivatives.
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HK1030218A1 (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same.
IL123013A (en) Substituted imidazoles having biphenylsulfonyl substitution, and pharmaceutical compositions comprising them
HK1038884A1 (en) Medicinal compositions.
HUP0203505A3 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, and pharmaceutical compositions containing said compounds
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
ZA200005510B (en) Pharmaceutical composition.
ZA9811833B (en) Pharmaceutical compositions of uridine triphosphate.
HUP0004561A3 (en) Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
EG23760A (en) Novel pentasaccharides, processes for their preparation and pharmaceutical compositions containing them
IL140414A0 (en) Beta lactam compounds, processes for the preparation thereof and pharmaceutical compositions containing the same